Target intelligence / Profile preview

Immunoglobulin lambda variable 3-15 (pseudogene) (IGLV3-15)

Target
IGLV3-15
Molecular classification
Other
01

Overview

Immunoglobulin lambda variable 3-15 (IGLV3-15) is classified as a pseudogene within the immunoglobulin lambda variable gene family, located on chromosome 22q11.2. Pseudogenes like IGLV3-15 are genomic sequences similar to functional genes but are generally non-functional and do not produce active protein products. The immunoglobulin lambda variable gene family encodes the variable regions of immunoglobulin light chains, which are critical for antigen recognition and adaptive immune responses, but IGLV3-15 itself does not encode a functional immunoglobulin domain due to its pseudogene status. IGLV3-15 is consistently listed as a pseudogene in major gene databases and references, indicated by sources such as Sigma-Aldrich, BioGPS, VarSome, and Merck Millipore. Pseudogenes do not encode functional proteins and thus are not considered therapeutic targets, diagnostic biomarkers, or direct participants in disease pathways. No evidence supports its use as a drug target or clinical biomarker; it does not interact with drugs or have a known mechanism of therapeutic action. The presence of this gene in nomenclature tables and genetic maps (e.g., IMGT) is for genomic annotation and does not imply functional significance. The aliases listed are alternate gene symbol forms or legacy nomenclature. There is nothing to suggest this entry is misspelled or a non-existent gene; however, it is important to note it is a pseudogene and not a functional protein-coding gene, so using it as a target is scientifically incorrect.

Other names
IGLV315V2-10PIGLV3-15

Beyond the preview

Go deeper on Immunoglobulin lambda variable 3-15 (pseudogene) (IGLV3-15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 3-15 (pseudogene) (IGLV3-15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call